NewSpace: a vision of living systems in microgravity

Be it in the managerial, commercial or technological field, innovation drives business. Of course, you need to have a vision, a nose for current trends, but you must also have the capacity to put that innovation into action. Every day, space agencies worldwide enable creative experiments in space to take wing, for a wide range of clients.

Efforts made to conquer space have generated innumerable patents and inspired the development of whole new product categories. Between 2001 and 2021, the Center for the Advancement of Science in Space (CASIS) supported the sending of more than 500 payloads to the American national laboratory on the International Space Station (ISS) , 70% of which arose from the private sector, including projects from companies on the Fortune 500 list, innovative start-ups and large organisations.

Microgravity experimentation overcomes scientific challenges in many fields of life sciences or the medical sector, such as diagnosis, pharmacy, the discovery of new drugs, biotechnology and medicine in general. This new generation of space activities is contributing to NewSpace , the development of the commercial space sector offering a range of possibilities ranging from the design of more effective treatments to the development of new plant varieties better suited to extreme conditions. Microgravity offers a range of possibilities leading not just to new pro-ducts, but to entirely new categories which can fundamentally change the way we live.

In this article we present the benefits of microgravity research for medicine and life sciences.